FAERS Cardiovascular Drug Safety: Adverse Event Reports 2020–2025

312,039 structured adverse event reports for cardiovascular drugs from the FDA's FAERS database, covering the period from 2020 to 2025. The dataset includes serious adverse events such as hospitalization, life-threatening outcomes, and death. It was created by RubyIntelligence and last updated on June 17, 2026.

Use Cases

• Signal detection for cardiovascular drug safety based on reported adverse reactions.
• Analysis of patient outcome trends based on seriousness and outcome codes.
• Demographic profiling of adverse event reporters based on patient demographics.
• Geographic analysis of adverse event reporting patterns based on reporter country.

Strengths

• 312,039 records provide a substantial volume for analysis.
• Data covers a defined five-year period from 2020 to 2025.
• Focus on serious adverse events (hospitalization, life-threatening, death) increases clinical relevance.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is known, but specific data formats and file sizes are unknown.
• Data may reflect reporting bias inherent to the FAERS voluntary reporting system.

Provenance

Source

FDA FAERS (FDA Adverse Event Reporting System)

Collection Method

Structured adverse event reports submitted to the FDA.

Time Range

2020–2025

Freshness

Last updated 2026-06-17 06:24:17; freshness should be verified.